Ankara Etlik City Hospital
Çankaya, Ankara, 06170, Turkey (Türkiye)
Location status: Recruiting
Location contact
Atakan Sezgi, M.D.
CONTACT
Musa Zengin, Associate Professor
CONTACT
NCT Number: NCT07603336
This prospective randomized study aims to compare the effects of two intraoperative hemodynamic management strategies on early postoperative renal function in patients undergoing pancreaticoduodenectomy. Patients will be allocated to either mean arterial pressure-guided hemodynamic management or cardiac index-guided hemodynamic management during surgery.
Pancreaticoduodenectomy is a major abdominal surgical procedure associated with prolonged operative duration, considerable fluid shifts, blood loss, and hemodynamic instability. These factors may contribute to impaired renal perfusion and postoperative renal dysfunction. Although mean arterial pressure is commonly used to guide intraoperative hemodynamic management, blood pressure alone may not fully reflect systemic blood flow or tissue perfusion. Cardiac index-guided management may provide a more direct assessment of global circulatory adequacy.
The primary outcome of the study is the change in serum creatinine level from the preoperative baseline value to the postoperative 72nd hour. Secondary outcomes include intraoperative hemodynamic variables, fluid and vasopressor requirements, urine output, postoperative renal function parameters, length of intensive care unit and hospital stay, and 30-day mortality.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Çankaya, Ankara, 06170, Turkey (Türkiye)
Location status: Recruiting
Atakan Sezgi, M.D.
CONTACT
Musa Zengin, Associate Professor
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intraoperative hemodynamic management will be performed according to predefined mean arterial pressure targets during pancreaticoduodenectomy. Standard anesthetic care, fluid therapy, vasopressor use, and intraoperative monitoring will be applied according to institutional clinical practice.
Intraoperative hemodynamic management will be performed according to predefined cardiac index targets during pancreaticoduodenectomy. Cardiac index values will be monitored intraoperatively, and fluid therapy, vasopressor use, and inotrope administration will be adjusted according to the hemodynamic status of the patient and institutional clinical practice.
Time frame: Preoperative baseline and postoperative 72nd hour
The primary outcome is the change in serum creatinine level, calculated as the difference between the serum creatinine value measured at postoperative 72 hours and the preoperative baseline serum creatinine value.
Time frame: From anesthesia induction to the end of surgery
Hourly urine output will be recorded intraoperatively and expressed as mL/kg/hour.
Time frame: From anesthesia induction to the end of surgery
The total amount of crystalloid and colloid fluids administered intraoperatively will be recorded.
Time frame: Postoperative 0-6 hours, 24 hours, 48 hours, and 72 hours
Serum creatinine values will be recorded at predefined postoperative time points to evaluate renal function trends during the early postoperative period.
Contact information is provided by the study sponsor or research team.
Atakan Sezgi
CONTACT
Musa Zengin
CONTACT
Ankara Etlik City Hospital
Other Gov
Comparison of the Effects of Mean Arterial Pressure-Based and Cardiac Index-Based Intraoperative Hemodynamic Management on Postoperative Renal Function in Patients Undergoing Pancreaticoduodenectomy: A Prospective Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07318493
Pancreatoduodenectomy, Whipple Procedure
Akron, Ohio, United States
View Trial DetailsNCT07072897
Digestive System Diseases, Digestive System Neoplasms
Kathmandu, Bagmati, Nepal
View Trial DetailsNCT06123013
Acute Pain, Distal Pancreatectomy
Cleveland, Ohio, United States
View Trial DetailsNCT06413888
Delayed Gastric Emptying, Digestive System Diseases
Houston, Texas, United States
View Trial Details